TWI367751B - Pharmaceutical composition comprising rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction - Google Patents

Pharmaceutical composition comprising rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction

Info

Publication number: TWI367751B
Authority: TW; Taiwan
Prior art keywords: rapid; serotonin reuptake; selective serotonin; sexual dysfunction; pharmaceutical composition
Prior art date: 1999-09-03

Application number

TW098145182A

Other languages

English (en)

Other versions

TW201018459A (en

Inventor

Karl Bruce Thor

Original Assignee

Apbi Holdings Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-03

Filing date

2000-08-25

Publication date

2012-07-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22542905&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TWI367751(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-08-25 Application filed by Apbi Holdings Llc filed Critical Apbi Holdings Llc

2010-05-16 Publication of TW201018459A publication Critical patent/TW201018459A/zh

2012-07-11 Application granted granted Critical

2012-07-11 Publication of TWI367751B publication Critical patent/TWI367751B/zh

Links

201000001880 Sexual dysfunction Diseases 0.000 title abstract 2
229940124834 selective serotonin reuptake inhibitor Drugs 0.000 title abstract 2
239000012896 selective serotonin reuptake inhibitor Substances 0.000 title abstract 2
231100000872 sexual dysfunction Toxicity 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 1
238000000034 method Methods 0.000 abstract 1
206010036596 premature ejaculation Diseases 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
230000001568 sexual effect Effects 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Reproductive Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)

TW098145182A 1999-09-03 2000-08-25 Pharmaceutical composition comprising rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction TWI367751B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US15243599P	1999-09-03	1999-09-03

Publications (2)

Publication Number	Publication Date
TW201018459A TW201018459A (en)	2010-05-16
TWI367751B true TWI367751B (en)	2012-07-11

Family

ID=22542905

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
TW094107594A TW200524582A (en)	1999-09-03	2000-08-25	Pharmaceutical composition comprising rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
TW089117155A TWI312678B (en)	1999-09-03	2000-08-25	Pharmaceutical composition comprising dapoxetine for treating sexual dysfunction
TW098145182A TWI367751B (en)	1999-09-03	2000-08-25	Pharmaceutical composition comprising rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
TW094107594A TW200524582A (en)	1999-09-03	2000-08-25	Pharmaceutical composition comprising rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
TW089117155A TWI312678B (en)	1999-09-03	2000-08-25	Pharmaceutical composition comprising dapoxetine for treating sexual dysfunction

Country Status (34)

Country	Link
US (4)	US7718705B1 (zh)
EP (3)	EP1671628B1 (zh)
JP (1)	JP3194734B2 (zh)
KR (1)	KR100719977B1 (zh)
CN (1)	CN1222283C (zh)
AT (1)	ATE318135T1 (zh)
AU (1)	AU762934B2 (zh)
BE (1)	BE2012C040I2 (zh)
BG (1)	BG65677B1 (zh)
BR (1)	BR0014166A (zh)
CA (1)	CA2383785C (zh)
CY (1)	CY2012028I1 (zh)
CZ (1)	CZ299712B6 (zh)
DE (2)	DE122009000036I2 (zh)
DK (1)	DK1225881T3 (zh)
EA (1)	EA004101B1 (zh)
EE (1)	EE05315B1 (zh)
ES (2)	ES2393582T3 (zh)
FR (1)	FR12C0052I2 (zh)
HK (2)	HK1047545B (zh)
HR (1)	HRP20020189A2 (zh)
HU (1)	HU229150B1 (zh)
IL (2)	IL148159A0 (zh)
LU (1)	LU92204I2 (zh)
MX (1)	MXPA02001811A (zh)
MY (1)	MY125490A (zh)
NO (2)	NO330562B1 (zh)
NZ (1)	NZ517038A (zh)
PL (1)	PL211402B1 (zh)
SI (1)	SI1225881T1 (zh)
TW (3)	TW200524582A (zh)
UA (1)	UA75580C2 (zh)
WO (1)	WO2001017521A1 (zh)
ZA (1)	ZA200201407B (zh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6403597B1 (en)	1997-10-28	2002-06-11	Vivus, Inc.	Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
SI1225881T1 (sl) *	1999-09-03	2006-06-30	Apbi Holdings Llc	Uporaba dapoksetina, selektivnega zaviralca ponovnega privzema serotonina s hitrim pricetkom delovanja, za zdravljenje seksualne disfunkcije
JP4377585B2 (ja)	2001-03-16	2009-12-02	ディーエムアイバイオサイエンシズインコーポレイテッド	射精遅延の方法
JP2004531506A (ja)	2001-03-29	2004-10-14	ブリストル−マイヤーズ　スクイブ　カンパニー	選択的なセロトニン再取り込みインヒビターとしてのシクロプロピルインドール誘導体
CA2410966C (en) *	2002-11-01	2005-11-22	Craig J. Hudson	Sexual desire and performance enhancement with protein-bound tryptophan
AU2003903597A0 (en) *	2003-07-11	2003-07-24	Jakov Vaisman	Treatment of premature ejaculation
GB0318706D0 (en) *	2003-08-08	2003-09-10	Pfizer Ltd	Selective serotonin reuptake inhibitors in the treatment of disease
DE102009015702A1 (de)	2009-03-31	2010-10-07	Ratiopharm Gmbh	Tabletten enthaltend Dapoxetin und Trockenverarbeitungsverfahren zu deren Herstellung
DE102009058321A1 (de)	2009-12-15	2011-06-16	Ratiopharm Gmbh	Schmelztablette, enthaltend Dapoxetin
MX2013000001A (es)	2010-07-06	2013-05-01	Navipharm Co Ltd	Composición farmaceutica de liberacion prolongada y acción retardada que comprende dapoxetina para administaracion oral.
RU2463033C2 (ru) *	2010-08-06	2012-10-10	Василий Федорович Пятин	Способ лечения преждевременной эякуляции
CN103100085A (zh) *	2011-11-09	2013-05-15	上海兰蒂斯生物医药科技有限公司	一种药物组合物
CN103130660B (zh) *	2011-11-25	2014-09-17	厦门福满药业有限公司	一类达泊西汀的酸式盐及其晶体,以及晶体的制备方法
WO2014042416A1 (ko) *	2012-09-13	2014-03-20	주식회사 씨티씨바이오	다폭세틴 유리염기를 함유하는 경구용 조성물
KR101432905B1 (ko)	2012-12-11	2014-08-21	가톨릭대학교 산학협력단	다폭세틴을 유효성분으로 포함하는 유전적 통증 치료용 약학 조성물
WO2014190063A1 (en) *	2013-05-21	2014-11-27	Wynberg Jason B	Methods for the treatment of premature ejaculation
CN103735525B (zh) *	2014-02-12	2015-05-06	江苏仁寿药业有限公司	一种达泊西汀片剂及制备方法
US20180071269A1 (en)	2015-08-12	2018-03-15	Tianxin Wang	Therapeutical methods, formulations and nutraceutical formulations
WO2016025541A1 (en) *	2014-08-12	2016-02-18	Tianxin Wang	Therapeutical methods, formulations and nutraceutical formulations
WO2018102233A1 (en) *	2016-11-30	2018-06-07	Wang tian xin	Therapeutical methods, formulations and nutraceutical formulations
TR201620151A2 (en)	2016-12-30	2018-07-23	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	ORAL PHARMACEUTICAL COMPOSITIONS CONTAINING TADALAFIL AND DAPOXETIN
CN113181127A (zh) *	2021-05-07	2021-07-30	苏州康恒研新药物技术有限公司	一种盐酸达泊西汀微丸片的制备方法
CN113143879A (zh) *	2021-05-07	2021-07-23	苏州康恒研新药物技术有限公司	一种盐酸达泊西汀缓释片的制备方法
US11977085B1 (en)	2023-09-05	2024-05-07	Elan Ehrlich	Date rape drug detection device and method of using same

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3536809A (en)	1969-02-17	1970-10-27	Alza Corp	Medication method
US3598123A (en)	1969-04-01	1971-08-10	Alza Corp	Bandage for administering drugs
US3845770A (en)	1972-06-05	1974-11-05	Alza Corp	Osmatic dispensing device for releasing beneficial agent
US3916899A (en)	1973-04-25	1975-11-04	Alza Corp	Osmotic dispensing device with maximum and minimum sizes for the passageway
US4194009A (en) *	1974-01-10	1980-03-18	Eli Lilly And Company	Aryloxyphenylpropylamines for obtaining a psychotropic effect
US4314081A (en) *	1974-01-10	1982-02-02	Eli Lilly And Company	Arloxyphenylpropylamines
US4018895A (en) *	1974-01-10	1977-04-19	Eli Lilly And Company	Aryloxyphenylpropylamines in treating depression
US4008719A (en)	1976-02-02	1977-02-22	Alza Corporation	Osmotic system having laminar arrangement for programming delivery of active agent
US4207343A (en) *	1978-06-22	1980-06-10	Eli Lilly And Company	1-Phenyl-3-(substituted phenoxy)propylamines
US4329356A (en) *	1980-10-31	1982-05-11	Eli Lilly And Company	Treatment of hypertension with fluoxetine and l-5-hydroxytryptophane
IE58110B1 (en)	1984-10-30	1993-07-14	Elan Corp Plc	Controlled release powder and process for its preparation
US5135947A (en) *	1987-04-09	1992-08-04	Eli Lilly And Company	1-phenyl-3-naphthalenyloxypropanamines and their use as selective serotonin reuptake inhibitors
US4866046A (en)	1988-05-31	1989-09-12	Top Laboratories, Inc.	Low-dosage sublingual aspirin
US5082667A (en)	1988-06-07	1992-01-21	Abbott Laboratories	Solid pharmaceutical dosage in tablet triturate form and method of producing same
US5073543A (en)	1988-07-21	1991-12-17	G. D. Searle & Co.	Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
US5114976A (en)	1989-01-06	1992-05-19	Norden Michael J	Method for treating certain psychiatric disorders and certain psychiatric symptoms
IT1229203B (it)	1989-03-22	1991-07-25	Bioresearch Spa	Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US4940731A (en)	1989-08-30	1990-07-10	Pfizer Inc.	Method of treating premature ejaculation using sertraline
US5120548A (en)	1989-11-07	1992-06-09	Merck & Co., Inc.	Swelling modulated polymeric drug delivery device
US5733566A (en)	1990-05-15	1998-03-31	Alkermes Controlled Therapeutics Inc. Ii	Controlled release of antiparasitic agents in animals
US5589511A (en)	1990-08-13	1996-12-31	Sepracor Inc.	Method for treating migraine headaches using optically pure S(+) fluoxetine
US5151448A (en) *	1991-07-12	1992-09-29	Crenshaw Roger T	Method for treating premature ejaculation
US5151488A (en) *	1991-11-12	1992-09-29	The Mead Corporation	Liquid crystal polymers containing a repeating bisoxazole structure
US5580578A (en)	1992-01-27	1996-12-03	Euro-Celtique, S.A.	Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5248699A (en)	1992-08-13	1993-09-28	Pfizer Inc.	Sertraline polymorph
US5292962A (en)	1992-12-11	1994-03-08	Eli Lilly And Company	Intermediates to 1-phenyl-3-naphthalenyloxy-propanamines
US5591767A (en)	1993-01-25	1997-01-07	Pharmetrix Corporation	Liquid reservoir transdermal patch for the administration of ketorolac
ZA93694B (en) *	1993-02-01	1993-06-03	Lilly Co Eli	Pharmaceutical treatments.
US5276042A (en) *	1993-04-16	1994-01-04	Crenshaw Roger T	Treatment of premature ejaculation
IT1264965B1 (it)	1993-11-12	1996-10-17	Giorgio Cavallini	Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
JP3310982B2 (ja)	1994-04-22	2002-08-05	ペンテツク・フアーマシユーテイカルズ・インコーポレイテツド	男性の勃起機能不全を改善するための剤形及び方法
CA2134038C (en)	1994-06-16	1997-06-03	David Taiwai Wong	Potentiation of drug response
IT1270594B (it)	1994-07-07	1997-05-07	Recordati Chem Pharm	Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US5457121A (en)	1994-09-02	1995-10-10	Eli Lilly And Company	Cis-hexahydro-5-(1,2,3,4-tetrahydro-2-naphthalenyl)pyrrolo<3,4-c>pyrroles as inhibitors of serotonin reuptake
US5597826A (en) *	1994-09-14	1997-01-28	Pfizer Inc.	Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
ZA958725B (en)	1994-10-20	1997-04-16	Lilly Co Eli	Treatment of disorders with duloxetine
EP0714663A3 (en) *	1994-11-28	1997-01-15	Lilly Co Eli	Potentiation of drug responses by serotonin 1A receptor antagonists
US5789402A (en)	1995-01-17	1998-08-04	Eli Lilly Company	Compounds having effects on serotonin-related systems
US5576321A (en)	1995-01-17	1996-11-19	Eli Lilly And Company	Compounds having effects on serotonin-related systems
US5614523A (en)	1995-01-17	1997-03-25	Eli Lilly And Company	Compounds having effects on serotonin-related systems
US5627196A (en)	1995-01-17	1997-05-06	Eli Lilly And Company	Compounds having effects on serotonin-related systems
WO1996024353A1 (en)	1995-02-10	1996-08-15	Eli Lilly And Company	Methods of treating or preventing psychiatric disorders
US5624677A (en)	1995-06-13	1997-04-29	Pentech Pharmaceuticals, Inc.	Controlled release of drugs delivered by sublingual or buccal administration
BR9610960A (pt)	1995-10-13	1999-03-02	Neurosearch As	Derivados de 8-azabiciclo [3.2.1] oct -2- eno sua preparação e uso
US5758911A (en) *	1996-02-07	1998-06-02	Northrop Grumman Corporation	Linear motion wind driven power plant
US5897864A (en)	1996-05-23	1999-04-27	Cohen; Alan J.	Method for treating sexual dysfunction disorders with compositions containing ginkgo biloba
US5846982A (en)	1996-06-14	1998-12-08	Eli Lilly And Company	Inhibition of serotonin reuptake
US5912256A (en)	1996-06-20	1999-06-15	Eli Lilly And Company	Compounds having effects on serotonin-related systems
US5830500A (en) *	1996-07-22	1998-11-03	Pentech Pharmaceuticals, Inc.	Low dose fluoxetine tablet
US5672612A (en)	1996-09-09	1997-09-30	Pentech Pharmaceuticals, Inc.	Amorphous paroxetine composition
US6638948B1 (en)	1996-09-09	2003-10-28	Pentech Pharmaceuticals, Inc.	Amorphous paroxetine composition
US5910319A (en)	1997-05-29	1999-06-08	Eli Lilly And Company	Fluoxetine enteric pellets and methods for their preparation and use
JP2000514101A (ja)	1997-07-01	2000-10-24	ファイザー・インク	セルトラリン塩及びセルトラリンの持続性剤形
ID24673A (id)	1997-07-01	2000-07-27	Pfizer Prod Inc	Bentuk-bentuk penakaran larutan sertralina dalam kapsul gelatin
CN1475209A (zh)	1997-07-01	2004-02-18	�Ʒ�	舍曲林的缓释剂型
FR2765483B1 (fr) *	1997-07-04	2000-02-04	Philippe Gorny	Medicament destine a traiter les dysfonctions erectiles
US5922341A (en)	1997-10-28	1999-07-13	Vivus, Incorporated	Local administration of pharmacologically active agents to treat premature ejaculation
US6037360A (en)	1997-10-28	2000-03-14	Vivus, Incorporated	Administration of 5-HT3 receptor antagonists to treat premature ejaculation
US6228864B1 (en)	1997-10-28	2001-05-08	Vivus, Inc.	Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
UA66370C2 (en)	1997-12-16	2004-05-17	Lilly Co Eli	Arylpiperazines having activity to setotonin 1 receptors
PA8469101A1 (es)	1998-04-09	2000-09-29	Pfizer Prod Inc	Ligandos azabiciclicos de receptores 5ht1
JP2002518331A (ja)	1998-06-19	2002-06-25	イーライ・リリー・アンド・カンパニー	セロトニン再取り込みの阻害
US6303627B1 (en)	1998-06-19	2001-10-16	Eli Lilly And Company	Inhibitors of serotonin reuptake
FR2781671A1 (fr)	1998-07-28	2000-02-04	Synthelabo	Compositions pharmaceutiques contenant un inhibiteur de la recapture de la serotonine et leur application en therapeutique
US6150376A (en)	1998-08-05	2000-11-21	Georgetown University	Bi- and tri-cyclic aza compounds and their uses
NZ510756A (en)	1998-10-13	2003-05-30	Pfizer Prod Inc	Sertraline oral concentrate
AU4982300A (en) *	1999-05-06	2000-11-21	Pentech Pharmaceuticals, Inc.	Regimen and kit for amelioration of premature ejaculation
US20010003120A1 (en) *	1999-05-14	2001-06-07	M. D. Robert Hines	Method for treating erectile dysfunction
SI1225881T1 (sl) *	1999-09-03	2006-06-30	Apbi Holdings Llc	Uporaba dapoksetina, selektivnega zaviralca ponovnega privzema serotonina s hitrim pricetkom delovanja, za zdravljenje seksualne disfunkcije

2000
- 2000-08-22 SI SI200030828T patent/SI1225881T1/sl unknown
- 2000-08-22 NZ NZ517038A patent/NZ517038A/xx not_active IP Right Cessation
- 2000-08-22 KR KR1020027002870A patent/KR100719977B1/ko not_active Ceased
- 2000-08-22 AT AT00957264T patent/ATE318135T1/de active
- 2000-08-22 CZ CZ20020784A patent/CZ299712B6/cs not_active IP Right Cessation
- 2000-08-22 BG BG106461A patent/BG65677B1/bg unknown
- 2000-08-22 EP EP06002333A patent/EP1671628B1/en not_active Expired - Lifetime
- 2000-08-22 EP EP00957264A patent/EP1225881B1/en not_active Expired - Lifetime
- 2000-08-22 US US10/049,427 patent/US7718705B1/en not_active Expired - Lifetime
- 2000-08-22 UA UA2002031755A patent/UA75580C2/uk unknown
- 2000-08-22 MX MXPA02001811A patent/MXPA02001811A/es active IP Right Grant
- 2000-08-22 CA CA002383785A patent/CA2383785C/en not_active Expired - Lifetime
- 2000-08-22 DE DE122009000036C patent/DE122009000036I2/de active Active
- 2000-08-22 IL IL14815900A patent/IL148159A0/xx unknown
- 2000-08-22 DK DK00957264T patent/DK1225881T3/da active
- 2000-08-22 EE EEP200200107A patent/EE05315B1/xx active Protection Beyond IP Right Term
- 2000-08-22 AU AU68911/00A patent/AU762934B2/en not_active Expired
- 2000-08-22 ES ES06002333T patent/ES2393582T3/es not_active Expired - Lifetime
- 2000-08-22 ES ES00957264T patent/ES2256032T3/es not_active Expired - Lifetime
- 2000-08-22 EP EP07023209A patent/EP1889614A3/en not_active Withdrawn
- 2000-08-22 HU HU0202687A patent/HU229150B1/hu active Protection Beyond IP Right Term
- 2000-08-22 PL PL364924A patent/PL211402B1/pl unknown
- 2000-08-22 WO PCT/US2000/020788 patent/WO2001017521A1/en active IP Right Grant
- 2000-08-22 CN CNB008153132A patent/CN1222283C/zh not_active Ceased
- 2000-08-22 BR BR0014166-6A patent/BR0014166A/pt not_active Application Discontinuation
- 2000-08-22 DE DE60026146T patent/DE60026146T2/de not_active Expired - Lifetime
- 2000-08-22 EA EA200200324A patent/EA004101B1/ru not_active IP Right Cessation
- 2000-08-25 TW TW094107594A patent/TW200524582A/zh unknown
- 2000-08-25 TW TW089117155A patent/TWI312678B/zh not_active IP Right Cessation
- 2000-08-25 TW TW098145182A patent/TWI367751B/zh not_active IP Right Cessation
- 2000-08-29 JP JP2000259000A patent/JP3194734B2/ja not_active Expired - Lifetime
- 2000-08-29 MY MYPI20003983A patent/MY125490A/en unknown
2002
- 2002-02-14 IL IL148159A patent/IL148159A/en active IP Right Grant
- 2002-02-19 ZA ZA200201407A patent/ZA200201407B/en unknown
- 2002-02-28 HR HR20020189A patent/HRP20020189A2/hr not_active Application Discontinuation
- 2002-03-01 NO NO20021035A patent/NO330562B1/no not_active IP Right Cessation
- 2002-12-16 HK HK02109124.8A patent/HK1047545B/zh unknown
2004
- 2004-11-24 US US10/996,587 patent/US20050261377A1/en not_active Abandoned
- 2004-11-24 US US10/996,757 patent/US20050215617A1/en not_active Abandoned
2006
- 2006-11-30 HK HK06113173.6A patent/HK1091418A1/xx unknown
2012
- 2012-08-29 FR FR12C0052C patent/FR12C0052I2/fr active Active
- 2012-09-11 NO NO2012015C patent/NO2012015I2/no unknown
- 2012-10-11 BE BE2012C040C patent/BE2012C040I2/fr unknown
- 2012-10-23 CY CY2012028C patent/CY2012028I1/el unknown
2013
- 2013-05-23 LU LU92204C patent/LU92204I2/fr unknown
2014
- 2014-04-10 US US14/250,198 patent/US20140221497A1/en not_active Abandoned

Also Published As

Publication number	Publication date
FR12C0052I1 (zh)	2012-05-10
HK1047545B (zh)	2006-09-22
MY125490A (en)	2006-08-30
CA2383785A1 (en)	2001-03-15
EE200200107A (et)	2003-04-15
HU229150B1 (hu)	2013-09-30
NZ517038A (en)	2003-04-29
LU92204I2 (fr)	2013-07-23
ES2393582T3 (es)	2012-12-26
US20050215617A1 (en)	2005-09-29
EP1671628B1 (en)	2012-10-03
ES2256032T3 (es)	2006-07-16
MXPA02001811A (es)	2002-08-06
IL148159A0 (en)	2002-09-12
DE60026146T2 (de)	2006-08-17
NO20021035L (no)	2002-05-02
CY2012028I2 (el)	2017-04-05
JP2001089394A (ja)	2001-04-03
BG106461A (en)	2002-12-29
WO2001017521A1 (en)	2001-03-15
DE60026146D1 (de)	2006-04-27
FR12C0052I2 (fr)	2013-08-16
BG65677B1 (bg)	2009-06-30
JP3194734B2 (ja)	2001-08-06
IL148159A (en)	2009-11-18
PL364924A1 (en)	2004-12-27
CN1387432A (zh)	2002-12-25
CY2012028I1 (el)	2017-04-05
NO330562B1 (no)	2011-05-16
US20050261377A1 (en)	2005-11-24
EE05315B1 (et)	2010-08-16
HUP0202687A2 (hu)	2002-12-28
HK1047545A1 (en)	2003-02-28
HUP0202687A3 (en)	2006-03-28
BE2012C040I2 (zh)	2019-10-16
TW201018459A (en)	2010-05-16
HRP20020189A2 (en)	2004-02-29
US20140221497A1 (en)	2014-08-07
DE122009000036I1 (de)	2009-11-05
UA75580C2 (uk)	2006-05-15
EP1889614A3 (en)	2010-09-22
EP1889614A2 (en)	2008-02-20
NO20021035D0 (no)	2002-03-01
EP1671628A1 (en)	2006-06-21
NO2012015I2 (no)	2013-08-26
SI1225881T1 (sl)	2006-06-30
CZ2002784A3 (cs)	2002-09-11
CN1222283C (zh)	2005-10-12
KR100719977B1 (ko)	2007-05-21
ZA200201407B (en)	2003-07-30
CZ299712B6 (cs)	2008-10-29
AU762934B2 (en)	2003-07-10
HK1091418A1 (en)	2007-01-19
AU6891100A (en)	2001-04-10
PL211402B1 (pl)	2012-05-31
DE122009000036I2 (de)	2010-05-06
NO2012015I1 (no)	2012-09-11
EP1225881B1 (en)	2006-02-22
TW200524582A (en)	2005-08-01
TWI312678B (en)	2009-08-01
EA004101B1 (ru)	2003-12-25
CA2383785C (en)	2009-02-17
BR0014166A (pt)	2002-05-14
EA200200324A1 (ru)	2002-08-29
DK1225881T3 (da)	2006-06-12
US7718705B1 (en)	2010-05-18
ATE318135T1 (de)	2006-03-15
KR20020025252A (ko)	2002-04-03
EP1225881A1 (en)	2002-07-31

Legal Events

Date	Code	Title	Description
2020-10-01	MK4A	Expiration of patent term of an invention patent

Publication	Publication Date	Title
HK1091418A1 (en)	2007-01-19	Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
ATE375341T1 (de)	2007-10-15	Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
BR0111800A (pt)	2003-05-27	Combinações de inibidores de depeptidil peptidase iv e outros agentes antidiabéticos para o tratamento de diabete mellitus
AU7040201A (en)	2002-01-14	A new use for deferiprone
MXPA03004288A (es)	2004-09-10	Tratamiento de disfuncion sexual inducida por farmaco antidepresivo con apomorfina.
WO2006002096A3 (en)	2006-05-04	Low doses of l-citrulline for treating diseases
TW200503666A (en)	2005-02-01	Treatment of type 1 diabetes with pde5 inhibitors
WO1999065475A3 (en)	2000-04-06	Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
PT1183046E (pt)	2003-12-31	Derivado de aminotetralina para a terapia de doencas cardiovasculares
MX9704887A (es)	1998-06-30	Composiciones farmaceuticas para el tratamiento de trastornos depresivos.